Stronger Sell Today AKBA ranks #4472 as SELL CANDIDATE #4472 Weaker Sell

AKBA stock forecast Akebia Therapeutics

AKBA stock forecast





AKBA Forecast and Technical Stock Analysis

Sell candidate since 2019-07-01 Loss -16.02%

Akebia Therapeutics gained 1.04% in the last trading day ( Friday, 19th Jul 2019 ), rising from $3.84 to $3.88 During day the stock fluctuated 5.59% from a day low at $3.76 to a day high of $3.97. The price has fallen in 6 of the last 10 days and is down by -11.42% for this period. Volume fell in the last day by -235 556 shares, and in total, 707 620 shares bought and sold for approximately $2.75 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Quick summary:

  • 30 day high of the AKBA stock price was $5.00 and low was $3.72.
  • 90 day high was $6.78 and low was $3.72.
  • 52 week high for the Akebia Therapeutics - $10.73 and low - $3.72.
Top Trending Stocks


Akebia Therapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -38.39% during the next 3 months and, with 90% probability hold a price between $1.85 and $2.62 at the end of this period.

Top Golden Star Stocks


A buy signal was issued from a pivot bottom point on Thursday July 18, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Akebia Therapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $4.06 and $4.33. A break-up above any of these levels will issue buy signals.

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

The stock currently holds a RSI14 at 18 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

* uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Support & Resistance

Akebia Therapeutics finds support from accumulated volume at $3.84.

Support: $3.84 Price: $3.88 Resistance: $4.42


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.21 between high and low, or 5.59%. For the last week, the stock has had a daily average volatility of 5.78%.

Akebia Therapeutics is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

5.78 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Sell Candidate Upgraded


Akebia Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.

Stronger Sell Today AKBA ranks #4472 as SELL CANDIDATE #4472 Weaker Sell

Will AKBA stock price go up or down on Mon, 22 Jul 2019?

Trading With Moving Average
As an investor, you always seek to understand what other... Full Article
Pivot Points
Pivot Points refer to points of significant change. As a... Full Article
Accumulated Volume - Support and Resistance
Volume is perhaps the best indicator of all and should... Full Article
Volume - The Indicator You Really Need to Know
Many new traders getting into the world of technical analysis... Full Article
We Give Back!
In 2016 donated to NGO Goodwill projects to help purchase medical... Full Article
Better Buy: Amazon vs. Facebook
Amazon's stock slipped 21% over the past six months, as... Full Article

Proudly made at